hotspot -WSS

hotspot

author：comprehensive 2025-09-30 12:16:56 - browse：4292

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Wikipedia

hotspot

WSS

Researchers tackle phage therapy hurdles for wider adoption

Indictment alleges Trump's ex

Biden administration begins canceling student loan debt for 804,000 borrowers

Hospitals are piloting generative AI tools as regulators play catch

Surge in Apellis stock fueled by confidence in safety of its eye drug

Maui wildfire now ranks as the fifth

hotspot

hotspot

focus

Affirmative action in medical school literally saved lives

Secretariat’s lessons for human medicine

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Continuity nursing helped my family in our darkest PICU moments

Ukraine seeks to reclaim its role as a hub for clinical trials

After affirmative action ruling, medical educators look to 'holistic review'

Senators push IRS to launch nonprofit hospital probe

Walensky prepares to leave CDC — and Congress — behind

Maui wildfire now ranks as the fifth

hotspot

Medicare Advantage enrollment hits roughly 33.4 million

Biogen’s boardroom scandal saddles CEO with first crisis

Judge sides with young activists in first

After Optum profits sink, UnitedHealth makes changes

Medicare Advantage enrollment hits roughly 33.4 million

FDA warns medical device makers about rise in fabricated data

leisure time

Wikipedia

hotspot

leisure time